SCHEMBL7323347

SCHEMBL7323347

O=C(Nc1ccc(-n2nc(C(F)(F)F)cc2C(F)(F)F)cc1)c1ccccc1O

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 4/20 0.67
ORAI1 Q96D31 3/20 0.66
TRPC3 Q13507 3/20 0.66
TRPC1 P48995 1/20 0.66
STIM1 Q13586 1/20 0.66
MAPT P10636 4/20 0.64
TRPC5 Q9UL62 1/20 0.59
CRACR2A Q9BSW2 1/20 0.57
THRB P10828 3/20 0.55
KDM4E B2RXH2 2/20 0.54
SMN1; SMN2 Q16637 1/20 0.53
P2RX1 P51575 2/20 0.52
P2RX4 Q99571 1/20 0.52
P2RX7 Q99572 1/20 0.52
EPHX2 P34913 2/20 0.50
LMNA P02545 2/20 0.49
MEN1 O00255 1/20 0.48
HPGD P15428 1/20 0.48
HTT P42858 1/20 0.48
KMT2A Q03164 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7326834 0.89 ORAI1 (0.75) TP53ORAI1TRPC3TRPC1STIM1
SCHEMBL7323681 0.89 KDM4E (0.69) TP53ORAI1TRPC3TRPC1STIM1
SCHEMBL7320077 0.89 TP53 (0.67) TP53ORAI1TRPC3TRPC1STIM1
SCHEMBL7326819 0.88 TP53 (0.66) TP53ORAI1TRPC3TRPC1STIM1
SCHEMBL7320259 0.88 ORAI1 (0.69) TP53ORAI1TRPC3TRPC1STIM1
SCHEMBL7318779 0.88 TP53 (0.66) TP53ORAI1TRPC3TRPC1STIM1
SCHEMBL7234017 0.88 TP53 (0.86) TP53ORAI1TRPC3TRPC1STIM1
SCHEMBL7317024 0.88 TP53 (0.66) TP53ORAI1TRPC3TRPC1STIM1
SCHEMBL7328795 0.88 TP53 (0.69) TP53ORAI1TRPC3TRPC1STIM1
SCHEMBL3277387 0.86 ORAI1 (0.73) TP53ORAI1TRPC3TRPC1STIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES 2001-11-22 US claimed
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES 2001-11-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION IL5, IL2, IL4 TP53 1903/4885ORAI1 3522/4885TRPC3 4362/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.